A team of French researchers has now built exactly that tool. Writing in PLOS Computational Biology, Chloé Weckel of the French National Research Institute for Agriculture, Food and the Environment and her colleagues, together with collaborators including Stefan Haar of the École Polytechnique and Romain Yvinec of INRAE, present a generic dynamic model of GPCR signaling that explicitly incorporates receptor trafficking: internalization from the plasma membrane, sorting inside endosomes, and recycling back to the surface. The work, published on September 29, 2026, is not merely another computational exercise. It is an attempt to make the spatial choreography of receptors a first-class citizen in theoretical models, rather than an afterthought, and then to test what that choreography actually contributes to a real hormonal response.

The central premise of the study is deceptively simple. If the kinetics and spatial localization of signaling determine how a cell responds to a ligand, then any model that ignores where the receptor is at a given moment is missing a critical variable. Receptors do not sit still. Ligand binding can trigger their internalization into endosomes, where they may continue to activate G proteins and other effectors, or they may be sorted for destruction. Many receptors are recycled back to the cell surface, replenishing the pool available for the next round of stimulation. Each of these steps has its own timescale, and each timescale feeds back into the shape of the signaling curve, how fast the response rises, how long it persists, and whether it is sustained or transient. The new model captures this interplay directly, allowing researchers to systematically characterize how endosomal dynamics and receptor recycling influence ligand-induced cellular responses.

What makes the approach powerful is its generality. Rather than hard-coding the behavior of one receptor, the authors constructed a framework in which trafficking and signaling compartmentalization are explicit, modular components. This means the same architecture can be adapted to different GPCRs by adjusting parameters, and, crucially, it means the model can be interrogated: which trafficking steps matter most for a given ligand, and under what conditions does endosomal signaling dominate over surface signaling? Such questions have real pharmacological weight. Two drugs that activate the same receptor with similar potency in a standard surface-based assay could produce very different cellular outcomes if one of them preferentially drives internalization or blocks recycling. A model that can distinguish these scenarios offers a far more refined instrument for characterizing ligands than conventional dose-response curves.

To prove the point, the team turned to a receptor with major biological and agricultural significance: the follicle-stimulating hormone receptor, or FSHR. FSH is the master regulator of reproductive function, driving follicle growth in the ovary and sperm production in the testis, and its receptor is a canonical GPCR whose signaling has been studied intensively. The researchers paired their model with high-throughput kinetic data on FSH-induced signaling, using a model selection strategy to determine which combinations of trafficking and signaling assumptions best explained the observed dynamics. This is where the study delivers its most striking surprise: although only a small fraction of FSH receptors is actually internalized, those few endosomal receptors generate a highly active signaling response inside the cell.

The implication of that finding is outsized. If a minority of internalized receptors can punch far above their numerical weight, then any drug or genetic perturbation that alters receptor trafficking, even modestly, could have dramatic consequences for the overall signaling output. A compound that speeds up internalization, slows recycling, or changes how receptors are sorted within endosomes would not merely shuffle receptors around; it would reshape the very profile of the cellular response. For reproductive medicine and livestock breeding, where FSHR ligands are used or studied therapeutically, this reframes how such molecules should be evaluated. A ligand’s pharmacological identity cannot be fully captured without knowing what it does to receptor traffic.

The study also speaks to a broader conceptual shift in cell biology. The emerging view of signaling holds that location is information: a receptor signaling from an endosome encounters a different set of effector molecules, scaffold proteins, and deactivating enzymes than it does at the plasma membrane, so the same receptor can produce qualitatively different downstream effects depending on where it is active. Endosomal signaling has been implicated in sustained responses such as the prolonged activity of certain receptors involved in neuronal function and metabolism. By building trafficking into a quantitative framework, the French team has provided a way to move this discussion from anecdote to arithmetic, converting a qualitative appreciation of spatial organization into testable, parameterized predictions.

Methodologically, the work sits at the intersection of dynamical systems modeling and high-throughput experimental biology. The model selection approach, in which competing mechanistic hypotheses are scored against kinetic data, allows the data themselves to adjudicate which trafficking behaviors are essential and which are dispensable for explaining the observed signaling. This discipline matters because GPCR systems are notoriously over-parameterized: with dozens of rate constants describing binding, internalization, degradation, recycling, and signaling at multiple locations, a model can easily become flexible enough to fit anything. By forcing the model to compete against real FSHR kinetics, the researchers ensured that the retained mechanisms, including the outsized contribution of endosomal signaling, earned their place in the explanation rather than being assumed from the outset.

The authors are careful to frame their contribution as generalizable. Beyond FSHR, the methodology offers a strategy for modeling trafficking dynamics across the GPCR superfamily, which includes receptors for neurotransmitters, hormones, sensory stimuli, and countless other ligands. Because the framework treats internalization, endosomal sorting, and recycling as explicit, tunable processes, it can in principle be calibrated to any receptor for which suitable kinetic data exist. That opens the door to a systematic, comparative pharmacology of trafficking: a future in which every ligand is characterized not only by how strongly it activates a receptor but by how it redistributes that receptor across the cell’s interior landscape.

For drug developers, the message is both a warning and an opportunity. The warning is that assays confined to the cell surface may systematically misjudge compounds whose most important effects occur inside endosomes, or whose toxicity and efficacy hinge on perturbing receptor recycling. The opportunity is that trafficking itself becomes a design target: molecules could be engineered to prolong or curtail endosomal signaling deliberately, tailoring not just the strength of a drug’s effect but its duration and spatial character. As the PLOS Computational Biology study makes clear, the journey of a receptor into the cell is not the end of its story. In many cases, it is where the real signaling begins, and understanding that journey quantitatively may prove as important to future pharmacology as the receptor itself.

Subject of Research: Spatiotemporal computational modeling of GPCR signaling, endosomal dynamics, and receptor recycling

Article Title: Spatiotemporal modeling of GPCR signaling: The role of endosomal dynamics and receptor recycling

Article References: Weckel, C., Gourdon, J., Darrigade, L., Jugnarain, V., Crépieux, P., Reiter, E., Jean-Alphonse, F., Haar, S., & Yvinec, R. (2026). Spatiotemporal modeling of GPCR signaling: The role of endosomal dynamics and receptor recycling. PLOS Computational Biology, 22(9), e1014790. https://doi.org/10.1371/journal.pcbi.1014790

Image Credits: AI Generated

DOI: 10.1371/journal.pcbi.1014790

Keywords: GPCR signaling, endosomes, receptor recycling, receptor trafficking, FSHR, computational biology, model selection, pharmacology, cell signaling, ligand characterization, PLOS Computational Biology, spatiotemporal modeling